Abstract
For the purposes of nosological classification of CTD and vasculitis, it is imperative to use a comprehensive, general therapeutic approach, which extends far beyond the boundaries of one specialization, including all internal and other clinical specialties.12, 14, 15, 21 In principle, any clinical symptom of these non-rheumatic diseases, without exception, could equally be a symptom of CTD and/or vasculitis. This variety and vague specificity of symptoms consequently makes the diagnostic pathway from symptom to diagnosis more difficult. One route, presented in this book, is to construct diagnostic blocks, i.e., syndromes and correlate them to one another. At the same time, the causal, morphological, and immunological factors need to be considered.2
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Benenson E. A program of diagnostic scrutiny in diffuse connective tissue diseases. Klin Revmatologiia (Mosk). 1998;1:12-16 [Russian].
Benenson E, Fries JW, Heilig B, et al. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide. Clin Rheumatol. 2005;24:251-257.
Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. Arthritis Rheum. 1992;35:630-640.
Gladman D, Ginzier E, Goldsmith C, et al. The development and initial evaluation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39:363-369.
Exley AR, Bacon PA, Lugmani RA, et al. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum. 1997;40:371-380.
Imboden JB, Hellmann DB, Stone JH. Current Rheumatology Diagnosis and Treatment. 2nd ed. New York: Lange Medical Books/McGraw-Hill; 2007.
Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitis. Arthritis Rheum. 1994;37:187-192.
Firestein CS, Budd RC, et al. Kelley’s Textbook of Rheumatology, Eighth Editions. Volume I and II. Philadelphia: W.B. Saunders; 2009.
Klippel JH, Stone JH, Crofford LE, White HP, eds. Primer on the Rheumatic Diseases. 13th ed. Springer Science+Business Media; 2008
Coding Guidelines of Rheumatology, Version 2010 [German].
Lugmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med. 1994;87:671-678.
Pile K, Kennedy L. Problem Solving in Rheumatology. Oxford: Clinical publishing; 2008.
Stone SJ, Stone JH, eds. A Clinician’s Pearls and Mythos in Rheumatology. London: Springer Science+Business Media BV; 2009.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer London
About this chapter
Cite this chapter
Benenson, E. (2011). Integrated Diagnostic Screening Program Staged Diagnostics. In: Rheumatology. Springer, London. https://doi.org/10.1007/978-1-84996-462-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-84996-462-3_13
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84996-461-6
Online ISBN: 978-1-84996-462-3
eBook Packages: MedicineMedicine (R0)